Soliman H - Search Results

1

Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.

Soliman H, Hogue D, Han H, Mooney B, Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Soyano A, Armaghani A, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Laronga C, Rosa M, Khong H, Czerniecki B. Soliman H, et al. Nat Med. 2023 Feb;29(2):450-457. doi: 10.1038/s41591-023-02210-0. Epub 2023 Feb 9. Nat Med. 2023. PMID: 36759673 Clinical Trial.

2

The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists.

Joh JE, Esposito NN, Kiluk JV, Laronga C, Lee MC, Loftus L, Soliman H, Boughey JC, Reynolds C, Lawton TJ, Acs PI, Gordan L, Acs G. Joh JE, et al. Among authors: soliman h. Oncologist. 2011;16(11):1520-6. doi: 10.1634/theoncologist.2011-0045. Epub 2011 Oct 20. Oncologist. 2011. PMID: 22016474 Free PMC article.

3

Pathologic tumor response of invasive lobular carcinoma to neo-adjuvant chemotherapy.

Joh JE, Esposito NN, Kiluk JV, Laronga C, Khakpour N, Soliman H, Catherine Lee M. Joh JE, et al. Among authors: soliman h. Breast J. 2012 Nov-Dec;18(6):569-74. doi: 10.1111/tbj.12006. Epub 2012 Oct 4. Breast J. 2012. PMID: 23034096 Clinical Trial.

4

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors.

Soliman HH, Jackson E, Neuger T, Dees EC, Harvey RD, Han H, Ismail-Khan R, Minton S, Vahanian NN, Link C, Sullivan DM, Antonia S. Soliman HH, et al. Oncotarget. 2014 Sep 30;5(18):8136-46. doi: 10.18632/oncotarget.2357. Oncotarget. 2014. PMID: 25327557 Free PMC article. Clinical Trial.

5

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival.

Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, Soliman H, Enderling H. Poleszczuk J, et al. Among authors: soliman h. Breast Cancer Res. 2017 Jun 30;19(1):75. doi: 10.1186/s13058-017-0870-1. Breast Cancer Res. 2017. PMID: 28666457 Free PMC article.

6

The clinical development of vaccines for HER2⁺ breast cancer: Current landscape and future perspectives.

Costa RLB, Soliman H, Czerniecki BJ. Costa RLB, et al. Among authors: soliman h. Cancer Treat Rev. 2017 Dec;61:107-115. doi: 10.1016/j.ctrv.2017.10.005. Epub 2017 Oct 28. Cancer Treat Rev. 2017. PMID: 29125981 Review.

7

A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer.

Soliman H, Khambati F, Han HS, Ismail-Khan R, Bui MM, Sullivan DM, Antonia S. Soliman H, et al. Oncotarget. 2018 Jan 10;9(11):10110-10117. doi: 10.18632/oncotarget.24118. eCollection 2018 Feb 9. Oncotarget. 2018. PMID: 29515795 Free PMC article.

8

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer.

Ahmed KA, Grass GD, Orman AG, Liveringhouse C, Montejo ME, Soliman HH, Han HS, Czerniecki BJ, Torres-Roca JF, Diaz R. Ahmed KA, et al. Among authors: soliman hh. Int J Breast Cancer. 2018 Jun 10;2018:6729802. doi: 10.1155/2018/6729802. eCollection 2018. Int J Breast Cancer. 2018. PMID: 29984003 Free PMC article. Review.

9

A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2⁺ breast cancer.

Costa R, Zaman S, Sharpe S, Helenowski I, Shaw C, Han H, Soliman H, Czerniecki B. Costa R, et al. Among authors: soliman h. Drug Des Devel Ther. 2019 Jan 14;13:309-316. doi: 10.2147/DDDT.S188925. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 30679903 Free PMC article. Review.

10

Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.

Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA. Figura NB, et al. Among authors: soliman h. Breast Cancer Res Treat. 2019 Jun;175(3):781-788. doi: 10.1007/s10549-019-05170-7. Epub 2019 Mar 11. Breast Cancer Res Treat. 2019. PMID: 30859348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

800 results

Search Page